Latest news

Insights

Top 10 Trends Driving Adaptive Clinical Trials

Executive Summary Clinical trials are becoming increasingly complex as pharmaceutical companies evaluate more targeted therapies, recruit diverse patient populations, and...
Clinical

Electra Plans to Advance Ipsoprubart Through Phase 2/3 sHLH Study

Electra Therapeutics plans to use proceeds from a proposed initial public offering to advance development of its lead drug...
Regulatory

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Scholar Rock has received U.S. Food and Drug Administration approval for apitegromab, an injectable monoclonal antibody that will be...
Clinical

J&J’s Depression Drug Fails Another Phase 2 Test

A phase 2 study of Johnson & Johnson’s JNJ-5120 has failed to achieve its primary goal, raising fresh questions...
Insights

Building a Future-Ready Life Sciences Organization

Executive Summary The life sciences industry is entering a period...
Regulatory

FDA Extends Review of Exelixis’ Zanzalintinib-Tecentriq Combination for Metastatic Colorectal Cancer

The U.S. Food and Drug Administration (FDA) has extended...
Commercial

Building on a “centuries-old bond,” Singapore establishes a biotech-focused Boston hub

With the original site of the international hotel chain having been established in Singapore almost 140 years ago, the...
Clinical

The Definium LSD medication wins another crucial anxiety study, making it 3 for 3

Definium Therapeutics has once again won in a phase 3 trial of its LSD formula, this time for the...
Insights

Top 10 AI Models Used in Drug Design

Executive Summary Artificial intelligence is changing drug design by enabling researchers to model biological structures, predict molecular interactions, generate new...
Insights

Why Multi-Omics Is Becoming a Strategic Priority in Life Sciences

Executive Summary Modern life sciences research is generating more biological...
Clinical

AbbVie’s Phase 3 Victory Opens Door For Qulipta Expansion

AbbVie has cleared another hurdle in its effort to...
Regulatory

The FDA halts enrollment in critical trials for the troubled epilepsy medication, dealing another blow to Biohaven

Biohaven stock fell more than 13% in premarket trading as the FDA slapped a partial clinical hold on its...
Insights

Remote Monitoring in Clinical Trials

Executive Summary Clinical trials are becoming increasingly decentralized, data-driven, and patient-centric. As sponsors conduct studies across more locations and seek...
Insights

The Rise of In Silico Clinical Trials

Executive Summary Clinical trials remain one of the most important and expensive stages of drug development. They provide essential evidence...
Regulatory

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Scholar Rock has received U.S. Food and Drug Administration...
Editorial Team -
Commercial

Otsuka and Ionis Pharmaceuticals partner for  Hereditary Angioedema Treatment

Japanese pharmaceutical company Otsuka Pharmaceutical has entered into a...
Commercial

Emergent Sells Travel Vaccine Portfolio to Bavarian Nordic For Over $270M

Following a challenging third quarter wherein Emergent BioSolutions reduced...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Scholar Rock has received U.S. Food and Drug Administration...
Editorial Team -
Clinical

Electra Plans to Advance Ipsoprubart Through Phase 2/3 sHLH Study

Electra Therapeutics plans to use proceeds from a proposed...
Regulatory

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Scholar Rock has received U.S. Food and Drug Administration...
Clinical

J&J’s Depression Drug Fails Another Phase 2 Test

A phase 2 study of Johnson & Johnson’s JNJ-5120...
Insights

Edge AI in Healthcare

Executive Summary Artificial intelligence is becoming increasingly embedded in healthcare,...

Research & Development

Market Access

Manufacturing

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...
Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Trends Driving Adaptive Clinical Trials

Executive Summary Clinical trials are becoming increasingly complex as pharmaceutical...
Editorial Team -
Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed...
Editorial Team -
Regulatory

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Scholar Rock has received U.S. Food and Drug Administration...
Editorial Team -